Literature DB >> 35854736

A Computational Framework for Identifying Age Risks in Drug-Adverse Event Pairs.

Zhizhen Zhao1, Ruoqi Liu2,3, Lei Wang3, Lang Li3, Chi Song4, Ping Zhang2,3,5.   

Abstract

The identification of associations between drugs and adverse drug events (ADEs) is crucial for drug safety surveillance. An increasing number of studies have revealed that children and seniors are susceptible to ADEs at the population level. However, the comprehensive explorations of age risks in drug-ADE pairs are still limited. The FDA Adverse Event Reporting System (FAERS) provides individual case reports, which can be used for quantifying different age risks. In this study, we developed a statistical computational framework to detect age group of patients who are susceptible to some ADEs after taking specific drugs. We adopted different Chi-squared tests and conducted disproportionality analysis to detect drug-ADE pairs with age differences. We analyzed 4,580,113 drug-ADE pairs in FAERS (2004 to 2018Q3) and identified 2,523 pairs with the highest age risk. Furthermore, we conducted a case study on statin-induced ADE in children and youth. The code and results are available at https://github.com/Zhizhen- Zhao/Age-Risk-Identification. ©2022 AMIA - All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35854736      PMCID: PMC9285161     

Source DB:  PubMed          Journal:  AMIA Annu Symp Proc        ISSN: 1559-4076


  17 in total

1.  Performance of Stratified and Subgrouped Disproportionality Analyses in Spontaneous Databases.

Authors:  Suzie Seabroke; Gianmario Candore; Kristina Juhlin; Naashika Quarcoo; Antoni Wisniewski; Ramin Arani; Jeffery Painter; Philip Tregunno; G Niklas Norén; Jim Slattery
Journal:  Drug Saf       Date:  2016-04       Impact factor: 5.606

Review 2.  Clarification of terminology in drug safety.

Authors:  Jeffrey K Aronson; Robin E Ferner
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

3.  Patient subgroup identification for clinical drug development.

Authors:  Xin Huang; Yan Sun; Paul Trow; Saptarshi Chatterjee; Arunava Chakravartty; Lu Tian; Viswanath Devanarayan
Journal:  Stat Med       Date:  2017-02-01       Impact factor: 2.373

Review 4.  A systematic review and meta-analysis of statin therapy in children with familial hypercholesterolemia.

Authors:  H J Avis; M N Vissers; E A Stein; F A Wijburg; M D Trip; J J P Kastelein; B A Hutten
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-06-14       Impact factor: 8.311

Review 5.  A comprehensive review and meta-analysis of risk factors for statin-induced myopathy.

Authors:  Khoa A Nguyen; Lang Li; Deshun Lu; Aida Yazdanparast; Lei Wang; Rolf P Kreutz; Elizabeth C Whipple; Titus K Schleyer
Journal:  Eur J Clin Pharmacol       Date:  2018-05-22       Impact factor: 2.953

6.  Reported adverse drug events in infants and children under 2 years of age.

Authors:  Thomas J Moore; Sheila R Weiss; Sigal Kaplan; Carol J Blaisdell
Journal:  Pediatrics       Date:  2002-11       Impact factor: 7.124

7.  Efficacy and safety of atorvastatin in children and adolescents with familial hypercholesterolemia or severe hyperlipidemia: a multicenter, randomized, placebo-controlled trial.

Authors:  Brian W McCrindle; Leiv Ose; A David Marais
Journal:  J Pediatr       Date:  2003-07       Impact factor: 4.406

8.  Age as a determinant of adverse events in medically treated cryptogenic stroke patients with patent foramen ovale.

Authors:  Shunichi Homma; Marco R DiTullio; Ralph L Sacco; Robert R Sciacca; J P Mohr
Journal:  Stroke       Date:  2004-07-01       Impact factor: 7.914

Review 9.  Developmental pharmacology--drug disposition, action, and therapy in infants and children.

Authors:  Gregory L Kearns; Susan M Abdel-Rahman; Sarah W Alander; Douglas L Blowey; J Steven Leeder; Ralph E Kauffman
Journal:  N Engl J Med       Date:  2003-09-18       Impact factor: 91.245

10.  Population Analysis of Adverse Events in Different Age Groups Using Big Clinical Trials Data.

Authors:  Jake Luo; Christina Eldredge; Chi C Cho; Ron A Cisler
Journal:  JMIR Med Inform       Date:  2016-10-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.